Spevigo (spesolimab)
pCPA File Number:
22963
Negotiation Status:
Under consideration for negotiation
Indication(s):
generalized pustular psoriasis (GPP)
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CDA-AMC Project Number:
SR0844-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable